DSIP (Delta Sleep-Inducing Peptide)

Does DSIP Actually Induce Sleep? What the Evidence Shows

UKPWritten and published by UK Peptides2 min readUpdated 2 cited sources

The short answer

The evidence is weak and unresolved. The original 1977 observation in rabbits has not been built into an accepted mechanism, no receptor has been identified through which such an effect could occur, and a 2006 review in the Journal of Neurochemistry characterised the sleep hypothesis as extremely poorly documented.

Key facts

Original observation
Delta EEG in rabbits, 1977
Receptor identified
No
Gene identified
No
Precursor protein
Not characterised
2006 review verdict
'A still unresolved riddle'
Field opinion
Divided since publication
Approved for sleep
Nowhere

What the original experiment showed

A fraction isolated from the cerebral venous blood of sleeping rabbits, administered into the ventricles of awake rabbits, was reported to increase delta-wave EEG activity. That is a real observation from a real experiment, and it is the entire foundation of the name. It is also a single species, an intraventricular route, and an EEG endpoint rather than a behavioural one.

Why the hypothesis never consolidated

A proposed endogenous signalling peptide normally becomes accepted biology by a recognisable route: the gene is found, the precursor is characterised, the receptor is identified, and the pathway is reconstructed. DSIP has completed none of these steps. Without a receptor there is no mechanism to test, and without a gene there is no way to knock it out and observe what happens. The two experiments that would settle the question are both unavailable.

Research material referenced

DSIP 5mg, third-party HPLC tested

Buy DSIP · £13.95

What the reviewers say

Kovalzon's 2006 review in the Journal of Neurochemistry is titled 'a still unresolved riddle', and describes the sleep hypothesis as extremely poorly documented. The field's own characterisation of DSIP has been divided since publication (described by some as a breakthrough and by others as a dead end), and three decades of subsequent work did not resolve that split.

Why a large literature is not the same as strong evidence

Roughly 519 indexed papers mention DSIP, which sounds substantial. Volume of publication reflects how interesting a question is, not how well it has been answered. A compound can accumulate hundreds of papers because the central claim keeps failing to resolve, with each new study a further attempt rather than a further confirmation.

How to read the vendor literature on this

Most commercial writing about DSIP presents the sleep effect as established, usually by restating the name and citing the 1977 paper. That is circular: the name came from the paper, and the paper is a single rabbit study. Anything asserting a demonstrated effect in humans is describing something the primary literature does not contain.

The position this site takes

DSIP is a compound with an interesting history, a clear structure, a real published literature and an unresolved central claim. That is worth describing accurately. It is not a sleep aid, we do not say it treats or improves anything, and its regulatory status is that of an unlicensed compound supplied for laboratory research.

Frequently asked questions

So does DSIP work?

For sleep, the evidence does not support a confident answer either way. The original rabbit observation was never built into an established mechanism, and no receptor is known.

Has anyone disproved it?

No, and that is part of the problem. The hypothesis has neither been confirmed nor definitively refuted, which is why reviewers describe it as unresolved rather than wrong.

Why is it still sold and studied?

It has a defined structure, a substantial published literature and an open scientific question attached to it. None of that constitutes evidence of an effect.

Continue researching

Related guides and reference material.

Primary sources & clinical trials

Published papers, trial registrations, regulator pages and company announcements. Links open the original.

Browse the wider literature

Live database searches, not fixed citations. Results change as new work is indexed.

UKP

Written and published by UK Peptides, the trading name of AURYXRESEARCH LTD (company 17388727, registered in England and Wales).

Questions or a correction? Email hello@ukpeptides.org or call +44 7426 987848.

Corrections log

More DSIP (Delta Sleep-Inducing Peptide) articles

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.